These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31597905)

  • 1. Micro-CT imaging analysis for the effects of ibandronate and eldecalcitol on secondary osteoporosis and arthritis in adjuvant-induced arthritis rats.
    Ono Y; Miyakoshi N; Kasukawa Y; Imai Y; Nagasawa H; Tsuchie H; Akagawa M; Nagahata I; Yuasa Y; Sato C; Kawatani M; Shimada Y
    Biomed Res; 2019; 40(5):197-205. PubMed ID: 31597905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of eldecalcitol and ibandronate on secondary osteoporosis and muscle wasting in rats with adjuvant-induced arthritis.
    Ono Y; Miyakoshi N; Kasukawa Y; Nagasawa H; Tsuchie H; Akagawa M; Nagahata I; Yuasa Y; Sato C; Shimada Y
    Osteoporos Sarcopenia; 2018 Dec; 4(4):128-133. PubMed ID: 30775555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined use of ibandronate and eldecalcitol in postmenopausal Japanese women with osteoporosis.
    Takada J; Wada H; Iba K; Sasaki K; Dohke T; Kanaya K; Yoshizaki T; Yamashita T
    J Orthop Surg (Hong Kong); 2016 Dec; 24(3):362-366. PubMed ID: 28031507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination treatment with ibandronate and eldecalcitol prevents osteoporotic bone loss and deterioration of bone quality characterized by nano-arrangement of the collagen/apatite in an ovariectomized aged rat model.
    Ozasa R; Saito M; Ishimoto T; Matsugaki A; Matsumoto Y; Nakano T
    Bone; 2022 Apr; 157():116309. PubMed ID: 34998980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eldecalcitol, an Active Vitamin D
    Takeda S; Saito M; Sakai S; Yogo K; Marumo K; Endo K
    Calcif Tissue Int; 2017 Oct; 101(4):433-444. PubMed ID: 28624935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
    Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
    Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone.
    Saito H; Takeda S; Amizuka N
    J Steroid Biochem Mol Biol; 2013 Jul; 136():178-82. PubMed ID: 23069645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further significant effects of eldecalcitol on bone resorption markers and bone mineral density in postmenopausal osteoporosis patients having undergone long-term bisphosphonate treatment.
    Iba K; Sonoda T; Takada J; Dohke T; Yamashita T
    J Bone Miner Metab; 2017 Mar; 35(2):171-176. PubMed ID: 26832388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of bone targeting salmon calcitonin analogues in rats developing osteoporosis and adjuvant arthritis.
    Bhandari KH; Asghar W; Newa M; Jamali F; Doschak MR
    Curr Drug Deliv; 2015; 12(1):98-107. PubMed ID: 25860966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of oral ibandronate 150 mg once monthly on bone structure and density in post-menopausal osteoporosis or osteopenia derived from in vivo μCT.
    Bock O; Börst H; Beller G; Armbrecht G; Degner C; Martus P; Roth HJ; Felsenberg D
    Bone; 2012 Jan; 50(1):317-24. PubMed ID: 22067902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of eldecalcitol on bone and skeletal muscles in glucocorticoid-treated rats.
    Kinoshita H; Miyakoshi N; Kasukawa Y; Sakai S; Shiraishi A; Segawa T; Ohuchi K; Fujii M; Sato C; Shimada Y
    J Bone Miner Metab; 2016 Mar; 34(2):171-8. PubMed ID: 25944421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with eldecalcitol and alendronate has therapeutic advantages over monotherapy by improving bone strength.
    Sakai S; Endo K; Takeda S; Mihara M; Shiraishi A
    Bone; 2012 May; 50(5):1054-63. PubMed ID: 22366400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eldecalcitol is less effective in suppressing parathyroid hormone compared to calcitriol in vivo.
    Harada S; Takeda S; Uno A; Takahashi F; Saito H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):281-3. PubMed ID: 20398764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three monthly intravenous injections of ibandronate in the treatment of postmenopausal osteoporosis.
    Thiébaud D; Burckhardt P; Kriegbaum H; Huss H; Mulder H; Juttmann JR; Schöter KH
    Am J Med; 1997 Oct; 103(4):298-307. PubMed ID: 9382122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of osteoporosis in patients with Crohn's disease: a randomized study comparing sodium fluoride and ibandronate.
    von Tirpitz C; Klaus J; Steinkamp M; Hofbauer LC; Kratzer W; Mason R; Boehm BO; Adler G; Reinshagen M
    Aliment Pharmacol Ther; 2003 Mar; 17(6):807-16. PubMed ID: 12641503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
    Bauss F; Lalla S; Endele R; Hothorn LA
    J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary osteoporosis in collagen-induced arthritis rats.
    Wu Q; Xiong X; Zhang X; Lu J; Zhang X; Chen W; Wu T; Cui L; Liu Y; Xu B
    J Bone Miner Metab; 2016 Sep; 34(5):500-16. PubMed ID: 26210858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combined treatment with ibandronate and pulsed electromagnetic field on ovariectomy-induced osteoporosis in rats.
    Zhou J; Liao Y; Xie H; Liao Y; Zeng Y; Li N; Sun G; Wu Q; Zhou G
    Bioelectromagnetics; 2017 Jan; 38(1):31-40. PubMed ID: 27711964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rat osteoporotic spine model for the evaluation of bioresorbable bone cements.
    Wang ML; Massie J; Perry A; Garfin SR; Kim CW
    Spine J; 2007; 7(4):466-74. PubMed ID: 17630145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibandronate in stable renal transplant recipients with low bone mineral density on long-term follow-up.
    Tillmann FP; Schmitz M; Jäger M; Krauspe R; Rump LC
    Int Urol Nephrol; 2016 Feb; 48(2):279-86. PubMed ID: 26498632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.